Monitoring Patient Improvement Parameters Following Pasireotide Treatment in Cushing’s Disease

Case Reports in Endocrinology- United States

doi 10.1155/2013/735489

Full Text

Abstract

Available in

Date

Authors

Publisher

Hindawi Limited

Related search

The Medical Treatment With Pasireotide in Cushing’s Disease: An Italian Multicentre Experience Based on “Real-World Evidence”

Endocrine
2019English

Managing Hyperglycemia in Patients With Cushing’s Disease Treated With Pasireotide: Medical Expert Recommendations

Pituitary
EndocrinologyMetabolismDiabetes
2013English

Erratum To: The Treatment With Pasireotide in Cushing’s Disease: Effects of Long–term Treatment on Tumor Mass in the Experience of a Single Center

Endocrine
2016English

Update on Medical Treatment for Cushing’s Disease

Clinical Diabetes and Endocrinology
EndocrinologyMetabolismDiabetes
2016English

Radiotherapy in Cushing’s Disease

Turkish Journal of Endocrinology and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

The Treatment With Pasireotide in Cushing’s Disease: Effect of Long-Term Treatment on Clinical Picture and Metabolic Profile and Management of Adverse Events in the Experience of a Single Center

Journal of Endocrinological Investigation
EndocrinologyMetabolismDiabetes
2019English

Pasireotide for a Patient With Acromegaly and Chronic Kidney Disease on Hemodialysis

AACE Clinical Case Reports
2019English

156 Improvement in Disease Severity in Patients With Treatment-Resistant Depression Following Treatment With Intranasal Esketamine

CNS Spectrums
PsychiatryMental HealthNeurology
2018English

Improvement of Diffusion Tensor Imaging (DTI) Parameters With Decoppering Treatment in Wilson’s Disease

JIMD Reports
Internal MedicineGeneticsMolecular BiologyBiochemistryEndocrinologyMetabolismDiabetes
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy